Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v4-FR
Language French French
Date Updated 2022-12-12 2022-11-15
Drug Identification Number 02266385 02266385
Brand name TARO-MOMETASONE LOTION TARO-MOMETASONE LOTION
Common or Proper name MOMETASONE MOMETASONE
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients MOMETASONE FUROATE MOMETASONE FUROATE
Strength(s) 0.1% 0.1%
Dosage form(s) LOTION LOTION
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 30ML 30ML
ATC code D07AC D07AC
ATC description CORTICOSTEROIDS, PLAIN CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-14 2022-10-14
Estimated end date 2022-12-02 2022-12-02
Actual end date 2022-12-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments